Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Heartbeam Inc (NQ: BEAT ) 2.750 -0.030 (-1.08%) Streaming Delayed Price Updated: 11:20 AM EDT, Jul 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Heartbeam Inc < Previous 1 2 3 4 5 6 Next > HeartBeam to Host Third Quarter 2023 Results Conference Call on Tuesday November 14, 2023 at 4:30 p.m. Eastern Time October 31, 2023 From HeartBeam, Inc. Via Business Wire BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Names Experienced Leaders to New Senior Management Positions September 26, 2023 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence Product Safety HeartBeam Appoints Richa Gujarati and Pooja Chatterjee to Senior Management Team September 26, 2023 From HeartBeam, Inc. Via Business Wire BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Q2 2023 Financial Report, Corporate Update August 11, 2023 Via Investor Brand Network Topics Artificial Intelligence Intellectual Property Exposures Artificial Intelligence Intellectual Property Product Safety HeartBeam Reports Second Quarter 2023 Financial Results August 10, 2023 From HeartBeam, Inc. Via Business Wire BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Announces First Peer-Reviewed Publication Based on Its VECG Technology August 09, 2023 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence HeartBeam Announces Publication of Foundational Study on the Detection of Heart Attacks August 09, 2023 From HeartBeam, Inc. Via Business Wire BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Appoints Deborah Castillo to Lead Regulatory Strategy and Execution August 08, 2023 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence Product Safety HeartBeam Appoints Deborah Castillo as Vice President of Regulatory Affairs August 08, 2023 From HeartBeam, Inc. Via Business Wire BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Host Q2 2023 Results Call, Webcast July 27, 2023 Via Investor Brand Network HeartBeam to Host Second Quarter 2023 Results Conference Call on Thursday August 10, 2023 at 4:30 p.m. Eastern Time July 27, 2023 From HeartBeam, Inc. Via Business Wire BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Names Experienced Physician, Researcher to Board of Directors July 26, 2023 Via Investor Brand Network HeartBeam Appoints Dr. Michael R. Jaff to the Board of Directors July 26, 2023 From HeartBeam, Inc. Via Business Wire BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Adds Wealth of Expertise to Its Board with Appointments of Ken Nelson and Mark Strome June 08, 2023 Via Investor Brand Network HeartBeam Appoints Ken Nelson and Mark Strome to the Board of Directors June 08, 2023 From HeartBeam, Inc. Via Business Wire Strategic Alliance with Samsung and Collaboration with Dept. of Veterans Affairs to Advance Use of Unique 3-D Telehealth Technology for Heart Attack Detection and Quicker Response: BEAT May 30, 2023 Via Get News BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Enters SAA with Samsung May 30, 2023 Via Investor Brand Network Exposures Product Safety InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Enters SAA with Samsung May 30, 2023 Via Investor Brand Network Exposures Product Safety HeartBeam (NASDAQ: BEAT) Enters Strategic Alliance Agreement with Samsung for Cardiac Care Solutions May 30, 2023 HeartBeam Collaborates with Samsung to Boost Cardiac Diagnostic Capabilities HeartBeam, Inc. (NASDAQ: BEAT), renowned for their pioneering 3D-vector electrocardiogram (VECG) Via Spotlight Growth Exposures Product Safety HeartBeam Enters into Strategic Alliance Agreement with Samsung May 30, 2023 From HeartBeam, Inc. Via Business Wire BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Granted Key Patent for Use in Innovative System Designed to Help Evaluate Cardiac Symptoms May 25, 2023 Via Investor Brand Network Topics Artificial Intelligence Intellectual Property Exposures Artificial Intelligence Intellectual Property HeartBeam Announces Automated Cardiac Detection Patent Granted for HeartBeam AIMIGo™ System May 25, 2023 From HeartBeam, Inc. Via Business Wire BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Announces FDA 510(k) Submission of HeartBeam AIMIGo(TM) Solution May 18, 2023 Via Investor Brand Network Exposures Product Safety HeartBeam Announces FDA Submission of HeartBeam AIMIGo™ VECG System May 18, 2023 From HeartBeam, Inc. Via Business Wire BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Q1 2023 Financial Report, Corporate Updates May 12, 2023 Via Investor Brand Network Exposures Product Safety HeartBeam Reports First Quarter 2023 Financial Results May 11, 2023 From HeartBeam, Inc. Via Business Wire $25 Million Capital Raise Completed to Support Commercialization of Unique 3-D Telehealth Technology for Heart Attack Detection and Rapid Response: HeartBeam, Inc. (NASDAQ: BEAT) May 03, 2023 Via Get News Topics Credit Cards Exposures Interest Rates Product Safety BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Completes $25M Capital Raise to Achieve Upcoming Milestones, Extend Cash Runway May 03, 2023 Via Investor Brand Network HeartBeam Completes $25 Million Capital Raise and Updates 2023 Strategic Focus and Financial Guidance May 03, 2023 From HeartBeam, Inc. Via Business Wire BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Poised to Offer Timely Solution amid a ‘Smoldering Public Health Crisis’ March 30, 2023 Via Investor Brand Network < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.